Evidence map›Paper›PMID 37634399›Full record

ArticleNuclear medicine and biology

Development of [

Mustafa T Kendirli, Rim Malek, Marina B Silveira, Christopher Acosta, Shuwen Zhang, Carmen Azevedo, Sydney C Nagy, Frezghi Habte, Michelle L James, Lawrence D Recht and 1 more

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Nuclear medicine and biology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.4field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 2 countries.

Mustafa T KendirliDepartment of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA 943065, USA.
Rim MalekDepartment of Radiology, Molecular Imaging Program at Stanford, Stanford University, Stanford, CA 943065, USA.
Marina B SilveiraDepartment of Radiology, Molecular Imaging Program at Stanford, Stanford University, Stanford, CA 943065, USA; Nuclear Technology Development Centre, National Nuclear Energy Commission, Belo Horizonte, MG 31270-901, Brazil.
Christopher AcostaDepartment of Radiology, Molecular Imaging Program at Stanford, Stanford University, Stanford, CA 943065, USA.
Shuwen ZhangDepartment of Radiology, Molecular Imaging Program at Stanford, Stanford University, Stanford, CA 943065, USA.
Carmen AzevedoDepartment of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA 943065, USA; Department of Radiology, Molecular Imaging Program at Stanford, Stanford University, Stanford, CA 943065, USA.
Sydney C NagyDepartment of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA 943065, USA; Department of Radiology, Molecular Imaging Program at Stanford, Stanford University, Stanford, CA 943065, USA.
Frezghi HabteDepartment of Radiology, Molecular Imaging Program at Stanford, Stanford University, Stanford, CA 943065, USA.
Michelle L JamesDepartment of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA 943065, USA; Department of Radiology, Molecular Imaging Program at Stanford, Stanford University, Stanford, CA 943065, USA.
Lawrence D RechtDepartment of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA 943065, USA.
Corinne BeinatDepartment of Radiology, Molecular Imaging Program at Stanford, Stanford University, Stanford, CA 943065, USA. Electronic address: cbeinat@stanford.edu.
Stanford University · USNational Nuclear Energy Commission · BR

Funding

Molecular Imaging of Pyruvate Kinase M2R21EB033524 · NIBIB · STANFORD UNIVERSITY · PI BEINAT, CORINNE · 2022 to 2024
$630k
Small animal PET system for molecular imaging of rodents and primatesS10OD018130 · OD · STANFORD UNIVERSITY · PI CHIN, FREDERICK T · 2014 to 2014
$600k
NIBIB NIH HHS R21 EB033524NIH HHS S10 OD018130
6 · The paper itself

Abstract

purposeThe aim of this study was to develop a positron emission tomography (PET) radiotracer for measuring pyruvate kinase M2 (PKM2) with improved physicochemical and pharmacokinetic properties compared to [ EXPERIMENTAL

designFirst, we synthesized [

results[

conclusion[

Indexed as

GliomaPyruvate KinaseAnimalsDiazonium CompoundsHeLa CellsHumansMiceMice, NudeRatsRNA, Small InterferingSulfanilic AcidsTissue Distributiondiazobenzenesulfonic acidDiazonium CompoundsPyruvate KinaseRNA, Small InterferingSulfanilic Acids[(18)F]DASA-10Brain tumor metabolismPET imagingPKM2

Identifiers

PMID37634399
PMCPMC10843576
OpenAlexW4386067579

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.